Jardiance (empagliflozin) Letter of Medical Necessity
Jardiance (empagliflozin) has multiple guideline-endorsed indications across cardiometabolic disease. PA denials are usually fixable by clarifying which indication is being treated.
FDA-Approved Indications
- ● type 2 diabetes mellitus
- ● heart failure (HFrEF and HFpEF)
- ● chronic kidney disease
- ● CV mortality risk reduction in T2DM
Why Jardiance Prior Authorization Gets Denied
The most common denial reasons across major payers:
- 1. Metformin trial missing
- 2. Renal function not documented
- 3. Heart failure indication not specified
What to Include in a Jardiance Letter of Medical Necessity
Document the specific indication being treated (T2DM, HFrEF, HFpEF, CKD), baseline labs (eGFR, A1c, NT-proBNP), prior therapy, and the relevant outcomes trial supporting use.
Key clinical evidence to cite:
- ✓ EMPA-REG OUTCOME
- ✓ EMPEROR-Reduced and EMPEROR-Preserved
- ✓ EMPA-KIDNEY trial
Relevant guidelines:
- 📖 ADA 2024 Standards of Care
- 📖 ACC/AHA/HFSA 2022 HF Guidelines
- 📖 KDIGO 2022 Diabetes in CKD
Jardiance Prior Authorization Criteria
Standard criteria across major US payers for Jardiance. Specific criteria vary by plan — RxCheckUp tailors each LMN to your patient's exact payer policy.
Typical step therapy requirements:
- → Metformin trial missing
Required documentation:
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy history with dates, doses, and discontinuation reasons
- ✓ Specialist evaluation (where applicable)
- ✓ Baseline disease activity or biomarker results
- ✓ Clinical rationale citing FDA labeling or guidelines
Approval details:
Initial approval: typically 6 months. Renewal: 12 months with documented clinical response.
Payers Covering Jardiance
RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:
Jardiance Prior Authorization FAQ
Why was my Jardiance prior authorization denied?
The most common denial reasons for Jardiance are: Metformin trial missing; Renal function not documented; Heart failure indication not specified.
What should a Jardiance Letter of Medical Necessity include?
Document the specific indication being treated (T2DM, HFrEF, HFpEF, CKD), baseline labs (eGFR, A1c, NT-proBNP), prior therapy, and the relevant outcomes trial supporting use.
Which payers cover Jardiance?
Jardiance is covered by major US payers including UnitedHealthcare, Aetna, Cigna, BCBS, Medicare Part D, though formulary tier and prior authorization criteria vary.